Your browser doesn't support javascript.
loading
ABREAST: a prospective, real-world study on the effect of nab-paclitaxel treatment on clinical outcomes and quality of life of patients with metastatic breast cancer.
Koumarianou, A; Makrantonakis, P; Zagouri, F; Papadimitriou, C; Christopoulou, A; Samantas, E; Christodoulou, C; Psyrri, A; Bafaloukos, D; Aravantinos, G; Papakotoulas, P; Baka, S; Andreadis, C; Alexopoulos, A; Bompolaki, I; Kampoli, Κ; Liori, S; Karvounis, K; Ardavanis, A.
Afiliación
  • Koumarianou A; Hematology Oncology Unit, Fourth Department of Internal Medicine, ATTIKON University General Hospital, National and Kapodistrian University of Athens, Medical School, Rimini 1, 124 62, Haidari, Athens, Greece. akoumari@yahoo.com.
  • Makrantonakis P; Second Chemotherapeutic Clinic, THEAGENIO Anti-Cancer Hospital of Thessaloniki, Thessaloniki, Greece.
  • Zagouri F; Therapeutic Clinic, ALEXANDRA General Hospital, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Papadimitriou C; Oncology Unit, 2nd Dept. of Surgery, ARETAIEIO University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Christopoulou A; Oncology Department, AGIOS ANDREAS General Hospital of Patras, Patras, Greece.
  • Samantas E; Third Oncology Clinic, AGIOI ANARGIROI Athens General Hospital, Athens, Greece.
  • Christodoulou C; Second Oncology Clinic, METROPOLITAN Athens Private Hospital, Piraeus, Greece.
  • Psyrri A; Division Medical Oncology, ATTIKON University General Hospital of Athens, Haidari, Greece.
  • Bafaloukos D; First Oncology Clinic, METROPOLITAN Athens Private Hospital, Piraeus, Greece.
  • Aravantinos G; Second Oncology Clinic, AGIOI ANARGIROI Athens General Hospital, Athens, Greece.
  • Papakotoulas P; First Chemotherapeutic Oncology Department, THEAGENION Anti-Cancer Hospital of Thessaloniki, Thessaloniki, Greece.
  • Baka S; Oncology Department, European INTERBALKAN Private Hospital of Thessaloniki, Thessaloniki, Greece.
  • Andreadis C; Third Department of Clinical Oncology and Chemotherapy, THEAGENION Anti-Cancer Hospital of Thessaloniki, Thessaloniki, Greece.
  • Alexopoulos A; Oncology Department, HYGEIA Athens Private Hospital, Maroussi, Athens, Greece.
  • Bompolaki I; Oncology Department, AGIOS GEORGIOS General Hospital of Chania, Chania, Crete, Greece.
  • Kampoli Κ; Hematology Oncology Unit, Fourth Department of Internal Medicine, ATTIKON University General Hospital, National and Kapodistrian University of Athens, Medical School, Rimini 1, 124 62, Haidari, Athens, Greece.
  • Liori S; First Department of Medical Oncology, AGIOS SAVVAS Athens General Hospital, Athens, Greece.
  • Karvounis K; Medical Department Hematology/Oncology, Genesis Pharma S.A, Halandri, Athens, Greece.
  • Ardavanis A; First Department of Medical Oncology, AGIOS SAVVAS Athens General Hospital, Athens, Greece.
Breast Cancer Res Treat ; 182(1): 85-96, 2020 Jul.
Article en En | MEDLINE | ID: mdl-32418045
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias de la Mama / Paclitaxel / Carcinoma Lobular / Carcinoma Ductal de Mama / Albúminas Límite: Aged / Female / Humans / Middle aged Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias de la Mama / Paclitaxel / Carcinoma Lobular / Carcinoma Ductal de Mama / Albúminas Límite: Aged / Female / Humans / Middle aged Idioma: En Año: 2020 Tipo del documento: Article